K. Itohara

发表

Population pharmacokinetic modeling of GS‐441524, the active metabolite of remdesivir, in Japanese COVID‐19 patients with renal dysfunction

T. Hirai, A. Yonezawa, T. Nakagawa, 2021, CPT: pharmacometrics & systems pharmacology.

Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data

Masayoshi Tanaka, M. Hayakari, S. Nakagawa, 2021, PloS one.

N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4

M. Hayakari, Masao Tanaka, S. Nakagawa, 2022, Pharmaceutical Research.

Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics

E. Hatano, S. Nakagawa, A. Yonezawa, 2022, Clinical and translational science.

Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study

Eiichiro Uchino, S. Nakagawa, A. Yonezawa, 2022, BMC Nephrology.

Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.

S. Nakagawa, A. Yonezawa, K. Matsubara, 2020, Biological & pharmaceutical bulletin.

Complete Deletion of Slc52a2 Causes Embryonic Lethality in Mice.

S. Nakagawa, A. Yonezawa, K. Matsubara, 2021, Biological & pharmaceutical bulletin.

Effect of riboflavin deficiency on development of the cerebral cortex in Slc52a3 knockout mice

S. Nakagawa, A. Yonezawa, K. Matsubara, 2020, Scientific Reports.

Significant effect of age on docetaxel pharmacokinetics in Japanese female breast cancer patients by using the population modeling approach

S. Masuda, I. Yano, K. Matsubara, 2016, European Journal of Clinical Pharmacology.

Infliximab Treatment Persistence among Japanese Patients with Chronic Inflammatory Diseases: A Retrospective Japanese Claims Data Study.

S. Nakagawa, A. Yonezawa, K. Matsubara, 2022, Biological & pharmaceutical bulletin.

MicroRNA-101 Regulates 6-Hydroxydopamine-Induced Cell Death by Targeting Suppressor/Enhancer Lin-12-Like in SH-SY5Y Cells

T. Nakagawa, I. Yano, S. Nakagawa, 2021, Frontiers in Molecular Neuroscience.

Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study

S. Nakagawa, A. Yonezawa, K. Matsubara, 2021, BMJ Open.

Extrapolation of physiologically based pharmacokinetic model for tacrolimus from renal to liver transplant patients.

O. Ogawa, Kotaro Itohara, I. Yano, 2021, Drug metabolism and pharmacokinetics.

Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

T. Murai, Kotaro Itohara, S. Nakagawa, 2022, Clinical neuropharmacology.

Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice.

S. Nakagawa, A. Yonezawa, K. Matsubara, 2021, American journal of physiology. Renal physiology.

Risk factors of breakthrough aspergillosis in lung transplant recipients receiving itraconazole prophylaxis.

H. Date, S. Nakagawa, A. Yonezawa, 2021, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

A Minimal Physiologically‐Based Pharmacokinetic Model for Tacrolimus in Living‐Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype

S. Uemoto, Kotaro Itohara, I. Yano, 2019, CPT: pharmacometrics & systems pharmacology.

A model-based pharmacokinetic assessment of drug–drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19

A. Uda, Kazuhiro Yamamoto, K. Itohara, 2023, Drug Metabolism and Pharmacokinetics.

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation

H. Date, S. Nakagawa, A. Yonezawa, 2022, Journal of Pharmaceutical Health Care and Sciences.

Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case series.

T. Hirai, M. Yanagita, N. Tanabe, 2023, Journal of Infection and Chemotherapy.

Significance of pharmacist intervention to oral antithrombotic therapy in the pharmaceutical outpatient clinic of cardiovascular internal medicine: a retrospective cohort study

T. Toba, Y. Habu, Kazuhiro Yamamoto, 2023, Journal of Pharmaceutical Health Care and Sciences.

The Efficacy of Bepotastine Besilate Compared With Hydroxyzine Pamoate for Preventing Infusion Reactions to the First Dose of Rituximab in Patients With Non-Hodgkin Lymphoma: Protocol for a Phase II, Double-Blind, Multicenter Randomized Trial

K. Yakushijin, Kazuhiro Yamamoto, T. Ioroi, 2023, JMIR research protocols.

Population pharmacokinetics of everolimus in renal transplant recipients receiving long-term multiple immunosuppressive therapy.

Kazuhiro Yamamoto, K. Itohara, Takahito Endo, 2024, Drug metabolism and pharmacokinetics.

Population Pharmacokinetic Modeling of Posaconazole in Japanese Patients Receiving Fungal Prophylaxis.

A. Takaori-Kondo, K. Yamashita, T. Kondo, 2024, Therapeutic drug monitoring.